Research Paper Volume 15, Issue 20 pp 11389—11411
Development of an immunogenic cell death prognostic signature for predicting clinical outcome and immune infiltration characterization in stomach adenocarcinoma
Figure 10. Somatic mutation landscape and MSI in GC. (A) Percent of MSI in low- and high-risk groups. (B) Distribution of risk score in MSS, MSI-L, and MSI-H. (C) TMB analysis. (D) Correlation analysis of TMB and ICDRG score. (E) Kaplan–Meier plotter for GC patients stratified ICDRG score and TMB. (F, G) The top 15 most frequently mutated genes in low- and high-risk groups.